Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied Transplant Research, indicate spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

Related Keywords

United States ,America ,William Werbel ,Allan Massie ,Lily Ramsey ,Trokhan Patterson ,Jennifer Alejo ,Teresa Chiang ,National Institute Of Diabetes ,Jazz Pharmaceuticals ,Johns Hopkins Transplant Research Center ,Real Time Learning Network ,National Institute Of Allergy ,National Institutes Of Health ,Johns Hopkins University School Of Medicine ,Infectious Diseases Society Of America ,Regeneron Pharmaceuticals ,Kamada Pharmaceuticals ,Novartis ,York University Center ,York University Grossman School Of Medicine ,Astrazeneca ,Mallinckrodt Pharmaceuticals ,Veloxis Pharmaceuticals ,New York University Center ,Applied Transplant Research ,Johns Hopkins University School ,National Institutes ,After Transplant ,Aura Abedon ,Johns Hopkins Medicine ,Dorry Segev ,New York University Grossman School ,National Institute ,Kidney Diseases ,Infectious Diseases ,Global Data ,Infectious Diseases Society ,Time Learning Network ,Thermo Fisher Scientific ,Covid 19 ,Transplant ,Allergy ,Electron ,Medicine ,Microscope ,Micron ,Pharmaceuticals ,Research ,Cars ,Ars Cov 2 ,Transmission Electron Microscope ,Virus ,